Brain Monitoring Market

Brain Monitoring Market by Devices (EEG, EMG, MEG, ICP, MRI, fMRI, CT) Accessories (Electrode, Sensor), Modality (Portable, Wearable), Indication (Stroke, TBI, Epilepsy, Headache, Sleep), End User (Hospital, Neurology center) & Region - Global Forecast to 2028

Report Code: MD 1369 Jan, 2024, by marketsandmarkets.com

The global brain monitoring market in terms of revenue was estimated to be worth $3.5 billion in 2023 and is poised to reach $4.8 billion by 2028, growing at a CAGR of 6.3% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The propulsion of the brain monitoring market primarily stems from the escalating occurrence and prevalence of neurological disorders, heightened awareness surrounding neurodegenerative diseases, a surge in traumatic brain injuries, and the expanded utilization of brain monitoring in clinical trials. Additionally, the increasing need for non-invasive and minimally invasive devices, the broadening therapeutic applications of brain monitoring tools, and the expanding healthcare sector in emerging economies are anticipated to offer growth opportunities for market players.

Global Brain Monitoring Market Trend

Brain Monitoring Market

To know about the assumptions considered for the study, Request for Free Sample Report

Brain Monitoring Market

Global Brain Monitoring Market Dynamics

Driver: Increasing incidence and prevalence of neurological disorders

The prevalence of various neurological disorders, encompassing dementia, epilepsy, Parkinson’s disease, Huntington’s disease, headache disorders, multiple sclerosis, neuroinfections, stroke, and cerebral palsy, has notably surged worldwide. Brain disorders, a compilation of developmental, psychiatric, and neurodegenerative ailments, are increasingly contributing to global morbidity rates. This escalation is primarily linked to the expanding elderly population, with projections indicating that over 20% of the global populace will be above 65 by 2050. Forecasts from the American Medical Association (AMA) suggest that by 2030, approximately 60% of individuals in this age bracket will contend with multiple chronic conditions.

The growing incidence of these neurological disorders underscores the critical need for monitoring brain and neurological functionalities. Many of these disorders are progressive and exhibit a heightened risk associated with aging. Furthermore, the rise in the prevalence of other ailments, such as sickle-cell diseases and cardiac disorders, contributes to this trend. Cardiac procedures, at times, impact normal brain functions, further accentuating the demand for brain monitoring devices.

Restraint: Research High cost of complex brain monitoring procedures and devices

The significant expense associated with brain monitoring surgeries and devices serves as a primary obstacle restraining the global brain monitoring market, particularly in developing nations with inadequate reimbursement policies. These devices are intricate, and their procedures typically incur substantial costs. For instance, a standard EEG averages around USD 200–700, with extended monitoring potentially reaching up to USD 3,000. Similarly, a dual-channel TCD costs approximately USD 3,000–3,200, while an ICP monitor ranges from USD 340–500. Furthermore, a single MEG system can cost about USD 2.5–3 million, posing a challenge for healthcare facilities to procure these devices, even in countries embracing advanced medical technology.

The high initial price, maintenance, and other indirect expenses significantly elevate these devices' overall ownership cost, limiting their widespread adoption. Budgetary constraints mainly affect small hospitals and independent Ambulatory Surgery Centers (ASCs), especially in developing nations, deterring their investment in costly, sophisticated technologies. Consequently, due to the prohibitive expense of these procedures and inadequate reimbursement conditions, only a small subset of patients in developing nations can afford neurological treatments. This financial constraint makes healthcare facilities hesitate to adopt new or technologically advanced systems, ultimately constraining the growth of the brain monitoring market.

Opportunity: The increasing demand for non-invasive and minimally invasive devices

Invasive monitoring procedures are intricate, uncomfortable, and carry inherent risks due to direct interaction with delicate brain tissue. Consequently, healthcare professionals and patients strongly prefer non-invasive or minimally invasive brain monitoring devices. The surge in demand for non-invasive alternatives such as ICP monitors, TCD devices, tympanic membrane displacement procedures, optic nerve sheath diameter assessments, CT scans/MRIs, and fundoscopy is attributed to their advantages over invasive methods. This heightened demand is compelling market players to focus on developing and commercializing such products.

Various government initiatives concentrate on fostering innovation in medical devices, notably exemplified by the BRAIN initiative introduced in the US in April 2013. This initiative aims to stimulate research and development in understanding brain function. Furthermore, the Advanced Research Projects Activity (IARPA) collaborates with the BRAIN initiative, explicitly targeting the creation of non-invasive neural intervention devices to enhance cognitive abilities in reasoning and problem-solving.

Challenge: Shortage of trained professional

Trained medical personnel are required to operate devices involved in the complex process of brain monitoring effectively. Positioning electrodes on the scalp and inserting muscular needles require accuracy and must be performed only by highly trained personnel. In addition, the results generated by brain monitoring machines are complex and can only be interpreted by qualified technicians or skilled professionals. These fundamental skills are necessary for end users to maximize the utility of their brain monitoring equipment. The presence of highly trained medical personnel and staff is, therefore, vital for effectively using brain monitoring equipment.

Global Brain Monitoring Market Ecosystem

Brain Monitoring Market Ecosystem

The devices segment accounted for the largest share of the brain monitoring industry

By product, the global brain monitoring market is categorized into devices and accessories. The devices segment held the largest share of the brain monitoring market in 2022. Mainly due to the rising prevalence of neurological, neurodegenerative, psychotic, and sleep disorders, it is coupled with the imperative for early detection, the availability of innovative portable and wearable monitoring devices tailored for home application, and an increasing awareness among patients.

Fixed devices accounted for the largest share of the modality segment of the brain monitoring industry

By modality, the global brain monitoring market is categorized into fixed, portable, and wearable. The fixed devices held the largest share of the brain monitoring market in 2022. Their established utilization in clinical environments like hospitals, specialized healthcare facilities, and research institutions is the reason behind their presence. These fixed devices are frequently regarded as the benchmark for comprehensive brain monitoring due to their precision, dependability, and advanced features.

The traumatic brain injury segment accounted for the largest share of the brain monitoring industry in 2022.

Based on medical condition, the brain monitoring market is segmented into traumatic brain injury (TBI), stroke, dementia, headache disorders, sleep disorders, Parkinson’s disease, epilepsy, Huntington’s disease, and other diseases. Traumatic brain injury (TBI) holds the largest share of the brain monitoring market by a medical condition. A key factor significantly boosting the market share of this segment is the notable rise in Traumatic Brain Injuries (TBIs) on a global scale. This upsurge in TBIs generates a considerable demand for handling such cases, leading to the widespread use of brain monitoring devices.

Hospitals accounted for the largest share of the end user segment of the brain monitoring industry

Based on end-users, the global brain monitoring devices market is segmented into hospitals, neurology centers, diagnostic centers, ASCs & clinics, and other end users. The hospital segment held the largest share of the global brain monitoring market in 2022. Brain monitoring requires complex procedures involving expensive and advanced devices primarily found in hospitals. Hospitals manage significantly higher patient volumes than smaller clinics and other end users. Additionally, the maintenance costs related to brain monitoring devices impose a considerable burden on healthcare facilities, with hospitals being better equipped to handle these expenses. Consequently, hospitals primarily use brain monitoring devices, contributing to their prevalence and larger market share within this segment.

North America accounted for the largest share of the global brain monitoring industry in 2022.

The brain monitoring market, by region, is segmented into North America, Europe, APAC, Latin America, and Middle East & Africa. North America accounted for the largest share of the brain monitoring market in 2022. This can be attributed to the growing incidence of neurological diseases, an increasing number of clinical trials of brain monitoring products, and the availability of medical reimbursement in the US.

Brain Monitoring Market by Region

To know about the assumptions considered for the study, download the pdf brochure

The global Brain Monitoring market is dominated by a few globally established players such as Medtronic (Ireland), Luciole Medical AG (Switzerland), Drägerwerk AG & Co. KGaA (Germany), Compumedics, Ltd. (Australia), Nonin Medical, Inc. (US), Integra LifeSciences Corporation (US), Advanced Brain Monitoring (US), Masimo Corporation (US), Unilabs holdings AB (Sweden), Cadwell Industries (US), NeuroWave Systems, Inc. (US), Natus Medical, Inc. (US), Nihon Kohden Corporation (Japan), Philips Healthcare (Netherlands), GE Healthcare (US), Siemens Healthineers (Germany), and Neurosoft (Russia).

Scope of the Brain Monitoring Industry

Report Metric

Details

Market Revenue in 2023

$3.5 billion

Projected Revenue by 2028

$4.8 billion

Revenue Rate

Poised to Grow at a CAGR of 6.3%

Market Driver

Increasing incidence and prevalence of neurological disorders

Market Opportunity

The increasing demand for non-invasive and minimally invasive devices

The study categorizes the Brain Monitoring market to forecast revenue and analyze trends in each of the following submarkets:

By Product

  • Devices
    • By Type
      • Magnetic Resonance Imaging (MRI) Scanners
      • Computerized Tomography (CT) Scanners
      • Electroencephalograph (EEG) Devices
      • Positron Emission Tomography (PET) Scanners
      • Sleep Monitoring Devices
      • Cerebral Oximeters
      • Electromyography (EMG) Devices
      • Intracranial Pressure (ICP) Monitors
      • Magnetoencephalography (MEG) Devices
      • Transcranial Doppler (TCD) Devices
    • Accessories
      • Electrodes
        • Wet Electrodes
        • Dry Electrodes
        • Needle Electrodes
      • Sensors
      • Pastes & Gels
      • Caps
      • Cables
      • Batteries
      • Other Accessories
    • By Usability
      • Disposable
      • Reusable

By Procedure

  • Devices for Invasive Procedures
  • Devices for Non-invasive Procedures

By Modality

  • Fixed
  • Portable
  • Wearable

By Medical Condition

  • Traumatic Brain Injury (TBI)
  • Stroke
  • Dementia
  • Headache Disorders
  • Sleep Disorders
  • Parkinson’s Disease
  • Epilepsy
  • Huntington's Disease
  • Other Medical Conditions

By End User

  • Hospitals
  • Neurology Centers
  • Ambulatory Surgery Centers (ASCs) & Clinics
  • Diagnostic Centers
  • Other End Users

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries

Recent Developments of Brain Monitoring Industry

  • In December 2023, Nihon Kohden introduced the One View feature in its Neuromaster G1 intraoperative neuromonitoring (IONM) system. This solution integrates the patient's anesthesia and vital signs, including heart rate, SpO2, temperature, and more, with neurological data embedded within the IONM software.
  • In October 2022, Medtronic is taking bold new steps to change that by launching the Medtronic Neurovascular Co-lab, an innovation process and platform for new ideas in treating stroke care.
  • In May 2021,  Medtronic and Viz.ai announced they are extending their successful US partnership to distribute Viz.ai’s “lifesaving” artificial intelligence (AI) software platform for stroke to Europe, the Middle East, and Africa (EMEA). The AI platform has been proven to synchronize stroke care, decrease treatment time, and improve patient outcomes.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 43)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
    1.3 INCLUSIONS & EXCLUSIONS 
    1.4 MARKET SCOPE 
           1.4.1 MARKETS COVERED
                    FIGURE 1 MARKET SEGMENTATION
           1.4.2 REGIONS COVERED
                    FIGURE 2 REGIONAL SEGMENTATION
           1.4.3 YEARS CONSIDERED
           1.4.4 CURRENCY CONSIDERED
    1.5 STAKEHOLDERS 
    1.6 RESEARCH LIMITATIONS 
           1.6.1 SCOPE-RELATED LIMITATIONS
           1.6.2 METHODOLOGY-RELATED LIMITATIONS
    1.7 SUMMARY OF CHANGES 
           1.7.1 IMPACT OF RECESSION
 
2 RESEARCH METHODOLOGY (Page No. - 49)
    2.1 RESEARCH DATA 
          FIGURE 3 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    FIGURE 4 PRIMARY SOURCES
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Insights from primary experts
                                FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
                                FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS, BY COMPANY TYPE, DESIGNATION, AND REGION
    2.2 MARKET SIZE ESTIMATION 
          FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
          FIGURE 8 COMPANY REVENUE ESTIMATION: NATUS MEDICAL, INC. (2022)
          FIGURE 9 MARKET REVENUE ESTIMATION: EEG MARKET
          FIGURE 10 BOTTOM-UP APPROACH
          FIGURE 11 TOP-DOWN APPROACH
          FIGURE 12 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN BRAIN MONITORING MARKET (2023–2028)
          FIGURE 13 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
          TABLE 1 MARKET ASSESSMENT FACTOR ANALYSIS
    2.3 MARKET BREAKDOWN & DATA TRIANGULATION 
          FIGURE 14 DATA TRIANGULATION METHODOLOGY
    2.4 STUDY ASSUMPTIONS 
    2.5 RISK ASSESSMENT 
          TABLE 2 RISK ASSESSMENT: BRAIN MONITORING MARKET
    2.6 IMPACT OF ECONOMIC RECESSION ON BRAIN MONITORING MARKET 
 
3 EXECUTIVE SUMMARY (Page No. - 66)
    FIGURE 15 BRAIN MONITORING MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
    FIGURE 16 BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2023 VS. 2028 (USD MILLION)
    FIGURE 17 BRAIN MONITORING MARKET, BY PROCEDURE, 2023 VS. 2028 (USD MILLION)
    FIGURE 18 BRAIN MONITORING MARKET, BY MODALITY, 2023 VS. 2028 (USD MILLION)
    FIGURE 19 BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2023 VS. 2028 (USD MILLION)
    FIGURE 20 BRAIN MONITORING MARKET, BY END USER, 2023–2028 (USD MILLION)
    FIGURE 21 REGIONAL SNAPSHOT: BRAIN MONITORING MARKET
 
4 PREMIUM INSIGHTS (Page No. - 71)
    4.1 BRAIN MONITORING MARKET OVERVIEW 
          FIGURE 22 INCREASING INCIDENCE AND PREVALENCE OF NEUROLOGICAL DISORDERS TO DRIVE MARKET
    4.2 BRAIN MONITORING MARKET, BY REGION 
          FIGURE 23 NORTH AMERICA TO COMMAND LARGEST MARKET SHARE DURING FORECAST PERIOD
    4.3 BRAIN MONITORING MARKET, BY PROCEDURE 
          FIGURE 24 NON-INVASIVE PROCEDURES AND JAPAN HELD LARGEST MARKET SHARE IN 2022
    4.4 GEOGRAPHIC SNAPSHOT: BRAIN MONITORING MARKET 
          FIGURE 25 CHINA TO REGISTER HIGHEST GROWTH RATE DURING STUDY PERIOD
    4.5 DEVELOPED VS. EMERGING ECONOMIES: BRAIN MONITORING MARKET 
          FIGURE 26 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING STUDY PERIOD
 
5 MARKET OVERVIEW (Page No. - 76)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 27 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES: BRAIN MONITORING MARKET
           5.2.1 DRIVERS
                    5.2.1.1 Increasing incidence and prevalence of neurological disorders
                    5.2.1.2 Rising awareness of neurodegenerative disorders
                    5.2.1.3 Growing incidence of traumatic brain injuries
                    5.2.1.4 Increased applications of brain monitoring devices in clinical trials
           5.2.2 RESTRAINTS
                    5.2.2.1 High cost of complex brain monitoring procedures and devices
                    5.2.2.2 Unfavorable reimbursement policies
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Increasing demand for non-invasive and minimally-invasive brain monitoring devices
                    5.2.3.2 Expanding therapeutic applications of brain monitoring devices
                    5.2.3.3 Growing healthcare market in emerging economies
           5.2.4 CHALLENGES
                    5.2.4.1 Shortage of trained medical professionals
                    5.2.4.2 Complex regulatory process and compliance framework
    5.3 INDUSTRY TRENDS 
           5.3.1 GRADUAL SHIFT TO VALUE-BASED AND PATIENT-CENTRIC CARE
           5.3.2 INNOVATIONS IN WEARABLE MEDICAL TECHNOLOGY
    5.4 PRICING ANALYSIS 
          TABLE 3 REGIONAL PRICING ANALYSIS OF KEY BRAIN MONITORING DEVICES
          TABLE 4 AVERAGE SELLING PRICE FOR REMOTE PATIENT MONITORING DEVICES, BY KEY PLAYER (2022)
    5.5 VALUE CHAIN ANALYSIS 
           5.5.1 RESEARCH & PRODUCT DEVELOPMENT
           5.5.2 RAW MATERIAL PROCUREMENT
           5.5.3 MANUFACTURING
           5.5.4 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES
                    FIGURE 28 VALUE CHAIN ANALYSIS: BRAIN MONITORING MARKET
    5.6 ECOSYSTEM MARKET/MAP 
          FIGURE 29 ECOSYSTEM MARKET/MAP: BRAIN MONITORING MARKET
    5.7 PORTER’S FIVE FORCES ANALYSIS 
          TABLE 5 PORTER’S FIVE FORCES ANALYSIS: BRAIN MONITORING MARKET
           5.7.1 THREAT OF NEW ENTRANTS
           5.7.2 THREAT OF SUBSTITUTES
           5.7.3 BARGAINING POWER OF SUPPLIERS
           5.7.4 BARGAINING POWER OF BUYERS
           5.7.5 INTENSITY OF COMPETITIVE RIVALRY
    5.8 TARIFF & REGULATORY ANALYSIS 
           5.8.1 TARIFF FOR BRAIN MONITORING DEVICES
           5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 6 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
           5.8.3 REGULATORY ANALYSIS
                    5.8.3.1 North America
                               5.8.3.1.1 US
                                              TABLE 7 US FDA: MEDICAL DEVICE CLASSIFICATION
                                              TABLE 8 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
                               5.8.3.1.2 Canada
                    5.8.3.2 Europe
                    5.8.3.3 Asia Pacific
                               5.8.3.3.1 Japan
                                              TABLE 9 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
                               5.8.3.3.2 China
                               5.8.3.3.3 India
    5.9 TECHNOLOGY ANALYSIS 
    5.10 PATENT ANALYSIS 
           5.10.1 PATENT PUBLICATION TRENDS
           5.10.2 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR BRAIN MONITORING PATENTS
                     FIGURE 30 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR BRAIN MONITORING PATENTS, 2011–2023
           5.10.3 MAJOR PATENTS IN BRAIN MONITORING MARKET
                     FIGURE 31 MAJOR PATENTS FOR BRAIN MONITORING DEVICES (2011–2023)
    5.11 TRADE ANALYSIS 
           FIGURE 32 PRODUCT IMPORTS UNDER HSN CODE: 901819, BY COUNTRY, 2022 (USD THOUSAND)
           FIGURE 33 PRODUCT EXPORTS UNDER HSN CODE 901819, BY COUNTRY, 2022 (USD THOUSAND)
    5.12 CASE STUDY ANALYSIS 
           TABLE 10 CASE STUDY 1: INTEGRATION OF GARMIN WEARABLE DEVICE DATA DIRECTLY INTO MEDTRONIC CARE MANAGEMENT SERVICES' (MCMS) BRAIN MONITORING PLATFORM
           TABLE 11 CASE STUDY 2: EPI-MINDER: A NOVEL IMPLANTABLE DEVICE FOR EPILEPSY MONITORING AND PREDICTION
    5.13 KEY CONFERENCES & EVENTS, 2023–2024 
           TABLE 12 LIST OF KEY CONFERENCES & EVENTS IN BRAIN MONITORING MARKET, 2023–2024
    5.14 KEY STAKEHOLDERS & BUYING CRITERIA 
           5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     TABLE 13 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR BRAIN MONITORING DEVICES
                     TABLE 14 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR BRAIN MONITORING DEVICES AND ACCESSORIES, BY TYPE
           5.14.2 BUYING CRITERIA
                     FIGURE 34 KEY BUYING CRITERIA FOR BRAIN MONITORING DEVICES, BY TYPE
                     TABLE 15 KEY BUYING CRITERIA FOR BRAIN MONITORING DEVICES
    5.15 UNMET NEEDS ANALYSIS & END USER EXPECTATIONS 
           TABLE 16 UNMET NEEDS IN BRAIN MONITORING MARKET
           5.15.1 END USER EXPECTATIONS
                     TABLE 17 END USER EXPECTATIONS IN BRAIN MONITORING MARKET
    5.16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 
           FIGURE 35 REVENUE SHIFTS AND NEW REVENUE POCKETS FOR BRAIN MONITORING MARKET
    5.17 REIMBURSEMENT SCENARIO ANALYSIS 
           TABLE 18 CPT CODES AND REIMBURSEMENT ANALYSIS IN BRAIN MONITORING MARKET IN US
    5.18 BUSINESS MODEL ANALYSIS 
    5.19 INVESTMENT AND FUNDING SCENARIO 
           FIGURE 36 INVESTOR DEALS AND FUNDING FOR BRAIN MONITORING DEVICES INCREASED IN 2022
           FIGURE 37 VALUATION OF KEY FIRMS IN BRAIN MONITORING MARKET IN 2022 (USD MILLION)
 
6 BRAIN MONITORING MARKET, BY PRODUCT (Page No. - 113)
    6.1 INTRODUCTION 
          TABLE 19 BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
    6.2 DEVICES 
          TABLE 20 BRAIN MONITORING MARKET FOR DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 21 BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
           6.2.1 EEG DEVICES
                    6.2.1.1 Growing R&D in cerebral and spinal disorders and increasing number of EEG laboratories to drive segment
                                TABLE 22 EEG DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.2 TCD DEVICES
                    6.2.2.1 Rising prevalence of strokes and cerebrovascular disorders to aid market growth
                                TABLE 23 TCD DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.3 MEG DEVICES
                    6.2.3.1 High implementation and maintenance costs to limit market
                                TABLE 24 MEG DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.4 ICP MONITORS
                    6.2.4.1 Increasing incidence of traumatic brain injuries and post-surgical cerebrovascular complications to propel market
                                TABLE 25 ICP MONITORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.5 CEREBRAL OXIMETERS
                    6.2.5.1 Increasing cases of hypoxia during surgical procedures to drive segment
                                TABLE 26 CEREBRAL OXIMETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.6 MRI SCANNERS
                    6.2.6.1 Technological advancements and rising number of neurological disorders to propel segment
                                TABLE 27 MRI SCANNERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.7 CT SCANNERS
                    6.2.7.1 Increasing preference for brain disease progression monitoring to drive segment
                                TABLE 28 CT SCANNERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.8 PET SCANNERS
                    6.2.8.1 Rising incidence of cancer to support market growth
                                TABLE 29 PET SCANNERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.9 SLEEP MONITORING DEVICES
                    6.2.9.1 Rising prevalence of sleep disorders to boost market growth
                                TABLE 30 SLEEP MONITORING DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.10 EMG DEVICES
                    6.2.10.1 Increasing prevalence of neuromuscular diseases to aid market growth
                                TABLE 31 EMG DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    6.3 ACCESSORIES 
          TABLE 32 BRAIN MONITORING MARKET FOR ACCESSORIES, BY COUNTRY, 2021–2028 (USD MILLION)
           6.3.1 BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE
                    TABLE 33 BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
                    6.3.1.1 Electrodes
                                TABLE 34 ELECTRODES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                               6.3.1.1.1 Wet electrodes
                                             6.3.1.1.1.1 Flexibility and high quality of signal recording to drive segment
                                                              TABLE 35 WET ELECTRODES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                               6.3.1.1.2 Dry electrodes
                                             6.3.1.1.2.1 Technological advancements and no requirement for skin preparation to aid market growth
                                                              TABLE 36 DRY ELECTRODES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                               6.3.1.1.3 Needle electrodes
                                             6.3.1.1.3.1 More accurate signals for diagnostic and therapeutic interventions to support market growth
                                                              TABLE 37 NEEDLE ELECTRODES MARKET, BY REGION, 2021–2028 (USD MILLION)
                    6.3.1.2 Sensors
                               6.3.1.2.1 Increasing patient preference for non-invasive procedures to drive market
                                              TABLE 38 SENSORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    6.3.1.3 Pastes & gels
                               6.3.1.3.1 Increasing demand for non-invasive methods of brain monitoring to aid market growth
                                              TABLE 39 PASTES & GELS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    6.3.1.4 Caps
                               6.3.1.4.1 Extended application of Infacaps for premature babies to propel segment
                                              TABLE 40 CAPS MARKET, BY REGION, 2021–2028 (USD MILLION)
                    6.3.1.5 Batteries
                               6.3.1.5.1 Increasing usage of portable and rechargeable devices to support segment growth
                                              TABLE 41 BATTERIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    6.3.1.6 Cables
                               6.3.1.6.1 Technological developments for increasing capabilities and cable lifespan to drive segment
                                              TABLE 42 CABLES MARKET, BY REGION, 2021–2028 (USD MILLION)
                    6.3.1.7 Other accessories
                                TABLE 43 OTHER ACCESSORIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.3.2 BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY
                    TABLE 44 BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
                    6.3.2.1 Disposable accessories
                               6.3.2.1.1 Growing physician preference for disposable accessories to propel market
                                              TABLE 45 DISPOSABLE ACCESSORIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    6.3.2.2 Non-disposable accessories
                               6.3.2.2.1 Increased usage of reusable accessories in emerging economies to boost segment growth
                                              TABLE 46 NON-DISPOSABLE ACCESSORIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
 
7 BRAIN MONITORING MARKET, BY PROCEDURE (Page No. - 142)
    7.1 INTRODUCTION 
          TABLE 47 BRAIN MONITORING MARKET, BY PROCEDURE, 2021–2028 (USD MILLION)
           7.1.1 NON-INVASIVE PROCEDURES
                    7.1.1.1 Limited risk of infections and hemorrhage to drive market
                                TABLE 48 BRAIN MONITORING MARKET FOR NON-INVASIVE PROCEDURES, BY COUNTRY, 2021–2028 (USD MILLION)
           7.1.2 INVASIVE PROCEDURES
                    7.1.2.1 Higher resolution imaging and detailed disease information to propel market
                                TABLE 49 BRAIN MONITORING MARKET FOR INVASIVE PROCEDURES, BY COUNTRY, 2021–2028 (USD MILLION)
 
8 BRAIN MONITORING MARKET, BY MODALITY (Page No. - 146)
    8.1 INTRODUCTION 
          TABLE 50 BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
    8.2 FIXED DEVICES 
           8.2.1 HIGH ACCURACY, MORE RELIABILITY, AND BETTER DIAGNOSIS TO AID MARKET GROWTH
                    TABLE 51 BRAIN MONITORING MARKET FOR FIXED DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)
    8.3 PORTABLE DEVICES 
           8.3.1 INCREASED MOBILITY AND COMFORT TO PROPEL MARKET GROWTH
                    TABLE 52 BRAIN MONITORING MARKET FOR PORTABLE DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)
    8.4 WEARABLE DEVICES 
           8.4.1 GREATER CONVENIENCE AND CONTINUOUS DATA COLLECTION TO DRIVE MARKET GROWTH
                    TABLE 53 BRAIN MONITORING MARKET FOR WEARABLE DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)
 
9 BRAIN MONITORING MARKET, BY MEDICAL CONDITION (Page No. - 151)
    9.1 INTRODUCTION 
          TABLE 54 COMPANIES OFFERING DEVICES FOR DIFFERENT MEDICAL CONDITIONS
          TABLE 55 BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
    9.2 TRAUMATIC BRAIN INJURY 
           9.2.1 GROWING INCIDENCE ACROSS ALL AGE GROUPS TO DRIVE MARKET
                    TABLE 56 BRAIN MONITORING MARKET FOR TRAUMATIC BRAIN INJURY, BY COUNTRY, 2021–2028 (USD MILLION)
    9.3 STROKE 
           9.3.1 GROWING GERIATRIC POPULATION AND RISING PREVALENCE OF CARDIOVASCULAR DISEASES TO SUPPORT MARKET GROWTH
                    TABLE 57 BRAIN MONITORING MARKET FOR STROKE, BY COUNTRY, 2021–2028 (USD MILLION)
    9.4 DEMENTIA 
           9.4.1 FAVORABLE GOVERNMENT INITIATIVES AND INCREASED ACCESS TO TREATMENT TO DRIVE MARKET
                    TABLE 58 BRAIN MONITORING MARKET FOR DEMENTIA, BY COUNTRY, 2021–2028 (USD MILLION)
    9.5 HEADACHE DISORDERS 
           9.5.1 RISING NUMBER OF INITIATIVES FOR HEADACHE DISORDERS TO PROPEL MARKET
                    TABLE 59 BRAIN MONITORING MARKET FOR HEADACHE DISORDERS, BY COUNTRY, 2021–2028 (USD MILLION)
    9.6 SLEEP DISORDERS 
           9.6.1 INCREASED STRESS AND UNHEALTHY LIFESTYLES AMONG ADULTS TO DRIVE MARKET
                    TABLE 60 BRAIN MONITORING MARKET FOR SLEEP DISORDERS, BY COUNTRY, 2021–2028 (USD MILLION)
    9.7 PARKINSON’S DISEASE 
           9.7.1 INCREASING GERIATRIC POPULATION TO AID MARKET GROWTH
                    TABLE 61 BRAIN MONITORING MARKET FOR PARKINSON’S DISEASE, BY COUNTRY, 2021–2028 (USD MILLION)
    9.8 EPILEPSY 
           9.8.1 RISING OCCURRENCE OF EPILEPSY AMONG ALL AGE GROUPS TO SUPPORT MARKET GROWTH
                    TABLE 62 BRAIN MONITORING MARKET FOR EPILEPSY, BY COUNTRY, 2021–2028 (USD MILLION)
    9.9 HUNTINGTON’S DISEASE 
           9.9.1 AVAILABILITY OF ADVANCED TREATMENT AND ONGOING RESEARCH TO AID MARKET GROWTH
                    TABLE 63 BRAIN MONITORING MARKET FOR HUNTINGTON’S DISEASE, BY COUNTRY, 2021–2028 (USD MILLION)
    9.10 OTHER MEDICAL CONDITIONS 
           TABLE 64 BRAIN MONITORING MARKET FOR OTHER MEDICAL CONDITIONS, BY COUNTRY, 2021–2028 (USD MILLION)
 
10 BRAIN MONITORING MARKET, BY END USER (Page No. - 165)
     10.1 INTRODUCTION 
            TABLE 65 BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
     10.2 HOSPITALS 
             10.2.1 HOSPITALS TO COMMAND LARGEST MARKET SHARE DURING FORECAST PERIOD
                        TABLE 66 BRAIN MONITORING MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION)
     10.3 NEUROLOGY CENTERS 
             10.3.1 PRESENCE OF HIGHLY EFFICIENT AND ADVANCED BRAIN MONITORING DEVICES TO PROPEL MARKET
                        TABLE 67 BRAIN MONITORING MARKET FOR NEUROLOGICAL CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
     10.4 DIAGNOSTIC CENTERS 
             10.4.1 FOCUS ON EARLY DIAGNOSIS AND TREATMENT OF NEUROGENERATIVE DISORDERS TO SUPPORT MARKET GROWTH
                        TABLE 68 BRAIN MONITORING MARKET FOR DIAGNOSTIC CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
     10.5 AMBULATORY SURGERY CENTERS & CLINICS 
             10.5.1 COST-EFFECTIVE AND MORE CONVENIENT TREATMENT OPTIONS TO AID MARKET GROWTH
                        TABLE 69 BRAIN MONITORING MARKET FOR AMBULATORY SURGERY CENTERS & CLINICS, BY COUNTRY, 2021–2028 (USD MILLION)
     10.6 OTHER END USERS 
             TABLE 70 BRAIN MONITORING MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
 
11 BRAIN MONITORING MARKET, BY REGION (Page No. - 173)
     11.1 INTRODUCTION 
             TABLE 71 BRAIN MONITORING MARKET, BY REGION, 2021–2028 (USD MILLION)
     11.2 NORTH AMERICA 
             FIGURE 38 NORTH AMERICA: BRAIN MONITORING MARKET SNAPSHOT
             TABLE 72 NORTH AMERICA: BRAIN MONITORING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 73 NORTH AMERICA: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
             TABLE 74 NORTH AMERICA: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 75 NORTH AMERICA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 76 NORTH AMERICA: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 77 NORTH AMERICA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
             TABLE 78 NORTH AMERICA: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
             TABLE 79 NORTH AMERICA: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
             TABLE 80 NORTH AMERICA: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
             TABLE 81 NORTH AMERICA: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.2.1 NORTH AMERICA: RECESSION IMPACT
             11.2.2 US
                        11.2.2.1 US to dominate North American brain monitoring market during forecast period
                                      TABLE 82 US: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 83 US: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 84 US: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 85 US: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 86 US: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
                                      TABLE 87 US: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
                                      TABLE 88 US: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
                                      TABLE 89 US: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
                                      TABLE 90 US: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.2.3 CANADA
                        11.2.3.1 Increasing number of hospitals and surgical centers to propel market
                                      TABLE 91 CANADA: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 92 CANADA: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 93 CANADA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 94 CANADA: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 95 CANADA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
                                      TABLE 96 CANADA: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
                                      TABLE 97 CANADA: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
                                      TABLE 98 CANADA: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
                                      TABLE 99 CANADA: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
     11.3 EUROPE 
             FIGURE 39 EUROPE: BRAIN MONITORING MARKET SNAPSHOT
             TABLE 100 EUROPE: BRAIN MONITORING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 101 EUROPE: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
             TABLE 102 EUROPE: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 103 EUROPE: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 104 EUROPE: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 105 EUROPE: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
             TABLE 106 EUROPE: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
             TABLE 107 EUROPE: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
             TABLE 108 EUROPE: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
             TABLE 109 EUROPE: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.3.1 EUROPE: RECESSION IMPACT
             11.3.2 GERMANY
                        11.3.2.1 Growing geriatric population and increasing life expectancy to aid market growth
                                      TABLE 110 GERMANY: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 111 GERMANY: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 112 GERMANY: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 113 GERMANY: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 114 GERMANY: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
                                      TABLE 115 GERMANY: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
                                      TABLE 116 GERMANY: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
                                      TABLE 117 GERMANY: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
                                      TABLE 118 GERMANY: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.3.3 FRANCE
                        11.3.3.1 Increasing prevalence of neurological disorders to drive market
                                      TABLE 119 FRANCE: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 120 FRANCE: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 121 FRANCE: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 122 FRANCE: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 123 FRANCE: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
                                      TABLE 124 FRANCE: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
                                      TABLE 125 FRANCE: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
                                      TABLE 126 FRANCE: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
                                      TABLE 127 FRANCE: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.3.4 UK
                        11.3.4.1 Increasing R&D investments by public and private sectors to boost market growth
                                      TABLE 128 UK: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 129 UK: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 130 UK: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 131 UK: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 132 UK: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
                                      TABLE 133 UK: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
                                      TABLE 134 UK: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
                                      TABLE 135 UK: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
                                      TABLE 136 UK: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.3.5 ITALY
                        11.3.5.1 Rising incidence of neurological disorders in aging population to drive market
                                      TABLE 137 ITALY: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 138 ITALY: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 139 ITALY: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 140 ITALY: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 141 ITALY: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
                                      TABLE 142 ITALY: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
                                      TABLE 143 ITALY: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
                                      TABLE 144 ITALY: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
                                      TABLE 145 ITALY: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.3.6 SPAIN
                        11.3.6.1 Increased burden of Parkinson’s disease to propel market
                                      TABLE 146 SPAIN: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 147 SPAIN: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 148 SPAIN: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 149 SPAIN: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 150 SPAIN: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
                                      TABLE 151 SPAIN: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
                                      TABLE 152 SPAIN: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
                                      TABLE 153 SPAIN: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
                                      TABLE 154 SPAIN: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.3.7 REST OF EUROPE
                        TABLE 155 REST OF EUROPE: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                        TABLE 156 REST OF EUROPE: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 157 REST OF EUROPE: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 158 REST OF EUROPE: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 159 REST OF EUROPE: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
                        TABLE 160 REST OF EUROPE: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
                        TABLE 161 REST OF EUROPE: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
                        TABLE 162 REST OF EUROPE: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
                        TABLE 163 REST OF EUROPE: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
     11.4 ASIA PACIFIC 
             TABLE 164 ASIA PACIFIC: BRAIN MONITORING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 165 ASIA PACIFIC: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
             TABLE 166 ASIA PACIFIC: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 167 ASIA PACIFIC: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 168 ASIA PACIFIC: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 169 ASIA PACIFIC: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
             TABLE 170 ASIA PACIFIC: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
             TABLE 171 ASIA PACIFIC: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
             TABLE 172 ASIA PACIFIC: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
             TABLE 173 ASIA PACIFIC: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.4.1 ASIA PACIFIC: RECESSION IMPACT
             11.4.2 JAPAN
                        11.4.2.1 High incidence of neurological disorders and large geriatric population to drive market
                                      TABLE 174 JAPAN: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 175 JAPAN: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 176 JAPAN: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 177 JAPAN: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 178 JAPAN: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
                                      TABLE 179 JAPAN: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
                                      TABLE 180 JAPAN: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
                                      TABLE 181 JAPAN: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
                                      TABLE 182 JAPAN: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.4.3 CHINA
                        11.4.3.1 Increasing number of government initiatives and growing incidence of neurological disorders to drive market
                                      TABLE 183 CHINA: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 184 CHINA: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 185 CHINA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 186 CHINA: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 187 CHINA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
                                      TABLE 188 CHINA: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
                                      TABLE 189 CHINA: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
                                      TABLE 190 CHINA: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
                                      TABLE 191 CHINA: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.4.4 INDIA
                        11.4.4.1 Improving healthcare infrastructure and rising public-private investment to support market growth
                                      TABLE 192 INDIA: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 193 INDIA: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 194 INDIA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 195 INDIA: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 196 INDIA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
                                      TABLE 197 INDIA: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
                                      TABLE 198 INDIA: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
                                      TABLE 199 INDIA: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
                                      TABLE 200 INDIA: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.4.5 REST OF ASIA PACIFIC
                        TABLE 201 REST OF ASIA PACIFIC: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                        TABLE 202 REST OF ASIA PACIFIC: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 203 REST OF ASIA PACIFIC: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 204 REST OF ASIA PACIFIC: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 205 REST OF ASIA PACIFIC: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
                        TABLE 206 REST OF ASIA PACIFIC: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
                        TABLE 207 REST OF ASIA PACIFIC: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
                        TABLE 208 REST OF ASIA PACIFIC: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
                        TABLE 209 REST OF ASIA PACIFIC: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
     11.5 LATIN AMERICA 
             TABLE 210 LATIN AMERICA: BRAIN MONITORING MARKET, BY REGION, 2021–2028 (USD MILLION)
             TABLE 211 LATIN AMERICA: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
             TABLE 212 LATIN AMERICA: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 213 LATIN AMERICA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 214 LATIN AMERICA: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 215 LATIN AMERICA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
             TABLE 216 LATIN AMERICA: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
             TABLE 217 LATIN AMERICA: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
             TABLE 218 LATIN AMERICA: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
             TABLE 219 LATIN AMERICA: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.5.1 LATIN AMERICA: RECESSION IMPACT
             11.5.2 BRAZIL
                        11.5.2.1 High cost of brain monitoring and imaging modalities to limit market growth
                                      TABLE 220 BRAZIL: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 221 BRAZIL: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 222 BRAZIL: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 223 BRAZIL: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 224 BRAZIL: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
                                      TABLE 225 BRAZIL: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
                                      TABLE 226 BRAZIL: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
                                      TABLE 227 BRAZIL: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
                                      TABLE 228 BRAZIL: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.5.3 MEXICO
                        11.5.3.1 Low tax rates and strong healthcare infrastructure to support market growth
                                      TABLE 229 MEXICO: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 230 MEXICO: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 231 MEXICO: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 232 MEXICO: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 233 MEXICO: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
                                      TABLE 234 MEXICO: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
                                      TABLE 235 MEXICO: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
                                      TABLE 236 MEXICO: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
                                      TABLE 237 MEXICO: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.5.4 REST OF LATIN AMERICA
                        TABLE 238 REST OF LATIN AMERICA: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                        TABLE 239 REST OF LATIN AMERICA: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 240 REST OF LATIN AMERICA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 241 REST OF LATIN AMERICA: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 242 REST OF LATIN AMERICA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
                        TABLE 243 REST OF LATIN AMERICA: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
                        TABLE 244 REST OF LATIN AMERICA: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
                        TABLE 245 REST OF LATIN AMERICA: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
                        TABLE 246 REST OF LATIN AMERICA: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
     11.6 MIDDLE EAST & AFRICA 
             TABLE 247 MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET, BY REGION, 2021–2028 (USD MILLION)
             TABLE 248 MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
             TABLE 249 MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 250 MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 251 MIDDLE EAST & AFRICA: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 252 MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
             TABLE 253 MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
             TABLE 254 MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
             TABLE 255 MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
             TABLE 256 MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.6.1 MIDDLE EAST & AFRICA: RECESSION IMPACT
             11.6.2 GCC COUNTRIES
                        11.6.2.1 Rising prevalence of Alzheimer’s and increasing number of government initiatives to drive market
                                      TABLE 257 GCC COUNTRIES: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 258 GCC COUNTRIES: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 259 GCC COUNTRIES: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 260 GCC COUNTRIES: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 261 GCC COUNTRIES: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
                                      TABLE 262 GCC COUNTRIES: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
                                      TABLE 263 GCC COUNTRIES: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
                                      TABLE 264 GCC COUNTRIES: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
                                      TABLE 265 GCC COUNTRIES: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.6.3 REST OF MIDDLE EAST & AFRICA
                        TABLE 266 REST OF MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                        TABLE 267 REST OF MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 268 REST OF MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 269 REST OF MIDDLE EAST & AFRICA: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 270 REST OF MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)
                        TABLE 271 REST OF MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
                        TABLE 272 REST OF MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)
                        TABLE 273 REST OF MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)
                        TABLE 274 REST OF MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)
 
12 COMPETITIVE LANDSCAPE (Page No. - 267)
     12.1 INTRODUCTION 
     12.2 KEY STRATEGIES/RIGHT TO WIN 
             TABLE 275 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN BRAIN MONITORING MARKET
     12.3 REVENUE SHARE ANALYSIS 
     12.4 MARKET SHARE ANALYSIS 
             FIGURE 41 MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022
             TABLE 276 DEGREE OF COMPETITION IN BRAIN MONITORING MARKET
             FIGURE 42 RANKING OF KEY COMPANIES IN BRAIN MONITORING MARKET, 2022
     12.5 COMPANY EVALUATION MATRIX 
             12.5.1 STARS
             12.5.2 EMERGING LEADERS
             12.5.3 PERVASIVE PLAYERS
             12.5.4 PARTICIPANTS
                        FIGURE 43 COMPANY EVALUATION MATRIX, 2022
             12.5.5 COMPANY FOOTPRINT
                        12.5.5.1 Overall footprint
                                      TABLE 277 BRAIN MONITORING MARKET: OVERALL FOOTPRINT
                        12.5.5.2 Product footprint
                                      TABLE 278 BRAIN MONITORING MARKET: PRODUCT FOOTPRINT
                        12.5.5.3 Procedure footprint
                                      TABLE 279 BRAIN MONITORING MARKET: PROCEDURE FOOTPRINT
                        12.5.5.4 Modality footprint
                                      TABLE 280 BRAIN MONITORING MARKET: MODALITY FOOTPRINT
                        12.5.5.5 Medical condition footprint
                                      TABLE 281 BRAIN MONITORING MARKET: MEDICAL CONDITION FOOTPRINT
                        12.5.5.6 End user footprint
                                      TABLE 282 BRAIN MONITORING MARKET: END USER FOOTPRINT
                        12.5.5.7 Regional footprint
                                      TABLE 283 BRAIN MONITORING MARKET: REGIONAL FOOTPRINT
     12.6 START-UP/SME EVALUATION MATRIX 
             12.6.1 PROGRESSIVE COMPANIES
             12.6.2 RESPONSIVE COMPANIES
             12.6.3 DYNAMIC COMPANIES
             12.6.4 STARTING BLOCKS
                        FIGURE 44 START-UP/SME EVALUATION MATRIX, 2022
             12.6.5 COMPETITIVE BENCHMARKING
                        TABLE 284 DETAILED LIST OF KEY START-UPS/SMES IN BRAIN MONITORING MARKET
     12.7 COMPETITIVE SCENARIO 
             12.7.1 PRODUCT LAUNCHES & APPROVALS
                        TABLE 285 BRAIN MONITORING MARKET: PRODUCT LAUNCHES & APPROVALS, 2020–2024
             12.7.2 DEALS
                        TABLE 286 BRAIN MONITORING MARKET: DEALS, 2020–2024
             12.7.3 OTHER DEVELOPMENTS
                        TABLE 287 BRAIN MONITORING MARKET: OTHER DEVELOPMENTS, 2020–2024
 
13 COMPANY PROFILES (Page No. - 287)
     13.1 KEY PLAYERS 
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
             13.1.1 NATUS MEDICAL INCORPORATED
                        TABLE 289 NATUS MEDICAL INCORPORATED: DEALS, 2020–2024
             13.1.2 NIHON KOHDEN CORPORATION
                        TABLE 290 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW
                        FIGURE 45 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2022)
                        TABLE 291 NIHON KOHDEN CORPORATION: PRODUCT LAUNCHES & APPROVALS, 2020–2024
             13.1.3 PHILIPS HEALTHCARE
                        TABLE 292 PHILIPS HEALTHCARE: COMPANY OVERVIEW
                        FIGURE 46 PHILIPS HEALTHCARE: COMPANY SNAPSHOT (2022)
                        TABLE 293 PHILIPS HEALTHCARE: DEALS, 2020–2024
             13.1.4 GE HEALTHCARE
                        TABLE 294 GE HEALTHCARE: COMPANY OVERVIEW
                        FIGURE 47 GE HEALTHCARE: COMPANY SNAPSHOT (2022)
                        TABLE 295 GE HEALTHCARE: DEALS, 2020–2024
             13.1.5 SIEMENS HEALTHINEERS AG
                        TABLE 296 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
                        FIGURE 48 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2023)
                        TABLE 297 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES & APPROVALS, 2020–2024
                        TABLE 298 SIEMENS HEALTHINEERS AG: DEALS, 2020–2024
             13.1.6 COMPUMEDICS LIMITED
                        TABLE 299 COMPUMEDICS LIMITED: COMPANY OVERVIEW
                        FIGURE 49 COMPUMEDICS LIMITED: COMPANY SNAPSHOT (2022)
                        TABLE 300 COMPUMEDICS LIMITED: PRODUCT LAUNCHES & APPROVALS, 2020–2024
                        TABLE 301 COMPUMEDICS LIMITED: DEALS, 2020–2024
             13.1.7 MEDTRONIC
                        TABLE 302 MEDTRONIC: COMPANY OVERVIEW
                        FIGURE 50 MEDTRONIC: COMPANY SNAPSHOT (2023)
             13.1.8 EDWARDS LIFESCIENCES CORPORATION
                        TABLE 303 EDWARDS LIFESCIENCES CORPORATION: COMPANY OVERVIEW
                        FIGURE 51 EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2022)
             13.1.9 ADVANCED BRAIN MONITORING, INC.
                        TABLE 304 ADVANCED BRAIN MONITORING, INC.: COMPANY OVERVIEW
             13.1.10 CADWELL INDUSTRIES, INC.
                        TABLE 305 CADWELL INDUSTRIES, INC: COMPANY OVERVIEW
                        TABLE 306 CADWELL INDUSTRIES, INC.: PRODUCT LAUNCHES & APPROVALS, 2020–2024
                        TABLE 307 CADWELL INDUSTRIES, INC.: DEALS, 2020–2024
             13.1.11 NEUROWAVE SYSTEMS, INC.
                        TABLE 308 NEUROWAVE SYSTEMS, INC.: COMPANY OVERVIEW
             13.1.12 NEUROSOFT
                        TABLE 309 NEUROSOFT: COMPANY OVERVIEW
             13.1.13 CGX
                        TABLE 310 CGX: COMPANY OVERVIEW
                        TABLE 311 CGX: OTHER DEVELOPMENTS, 2020–2024
             13.1.14 NONIN
                        TABLE 312 NONIN: COMPANY OVERVIEW
             13.1.15 RIMED
                        TABLE 313 RIMED: COMPANY OVERVIEW
                        TABLE 314 RIMED: DEALS, 2020–2024
             13.1.16 EMOTIV
                        TABLE 315 EMOTIV: COMPANY OVERVIEW
             13.1.17 DRÄGERWERK AG & CO. KGAA
                        TABLE 316 DRÄGERWERK AG & CO. KGAA: COMPANY OVERVIEW
                        FIGURE 52 DRÄGERWERK AG & CO. KGAA: COMPANY SNAPSHOT (2022)
             13.1.18 MASIMO CORPORATION
                        TABLE 317 MASIMO CORPORATION: COMPANY OVERVIEW
                        FIGURE 53 MASIMO CORPORATION: COMPANY SNAPSHOT (2021)
                        TABLE 318 MASIMO CORPORATION: DEALS, 2020–2024
             13.1.19 LUCIOLE MEDICAL AG
                        TABLE 319 LUCIOLE MEDICAL AG: COMPANY OVERVIEW
                        TABLE 320 LUCIOLE MEDICAL AG: DEALS, 2020–2024
             13.1.20 INTEGRA LIFESCIENCES
                        TABLE 321 INTEGRA LIFESCIENCES: COMPANY OVERVIEW
                        FIGURE 54 INTEGRA LIFE SCIENCES: COMPANY SNAPSHOT (2022)
     13.2 OTHER PLAYERS 
             13.2.1 INFRASCAN, INC.
             13.2.2 NEUSOFT MEDICAL SYSTEMS CO., LTD.
             13.2.3 NORAXON USA
             13.2.4 STERNMED GMBH
             13.2.5 CERIBELL
 
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
 
14 APPENDIX (Page No. - 340)
     14.1 DISCUSSION GUIDE 
     14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     14.3 CUSTOMIZATION OPTIONS 
     14.4 RELATED REPORTS 
     14.5 AUTHOR DETAILS 

The study involved four major activities in estimating the current size of the Brain Monitoring market. Exhaustive secondary research was done to collect information on the market and its different sub-segments. The next step was to validate these findings, assumptions, and market sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of the segments and sub-segments.

Secondary Research

This research study involved the extensive usage of secondary sources; directories; databases such as Bloomberg Business, Factiva, and Wall Street Journal; white papers and annual reports; company house documents; investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the brain monitoring market. It was also used to obtain important information about the key market players, market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information important for this report. Primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing directors, technology and innovation directors, and related executives from various key companies and organizations operating in the brain monitoring market. After the complete market engineering process (which includes calculations for market statistics, market breakdown, market size estimations, market forecasting, and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at.

Some of the major objectives of primary research are:

  • To validate market segmentation defined through an assessment of the product portfolios of leading players
  • To understand the key industry trends and technologies defining the strategic growth objectives of market players
  • To gather both demand- and supply-side validation of the key factors affecting the market growth
  • To validate assumptions for the market sizing and forecasting model used for this study
  • To understand the market position of leading players in the brain monitoring market and their market share/ranking

Breakdown Of Primary Participants

Brain Monitoring Market Size, and Share

*Others include sales managers, marketing managers, and product managers.

Note: Tiers are defined based on a company’s total revenue. As of 2019, Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the Brain Monitoring market. These methods were also used extensively to estimate the size of various subsegments in the market.

Bottom-up approach

The bottom-up procedure was adopted to arrive at the overall size of the Brain Monitoring market from the revenue of key players (companies), their shares in the market, and their annual sales of Brain Monitoring products.

Brain Monitoring Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Top-down approach

The overall Brain Monitoring market size was used in the top-down approach to estimate the sizes of other individual markets (mentioned in the market segmentation by product, medical condition, end user, and region) through percentage splits from secondary and primary research.

For the calculation of each type of specific market segment, the most appropriate immediate-parent market size was used for implementing the top-down approach. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained. Market shares were then estimated for top companies to verify the total market revenue arrived earlier in the bottom-up approach.

Brain Monitoring Market Size, and Share

Data Triangulation

After arriving at the overall market size, from the market size estimation process explained above, the Brain Monitoring market was split into segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Brain Monitoring industry.

Market Definition

Brain Monitoring is a procedure that monitors the activity of various parameters associated with the functioning of brain, which includes electrical activity, blood flow, magnetic activity, the pressure surrounding the brain, and cerebral oxygen saturation.

Key Stakeholders

  • World Health Organization (WHO)
  • National Center for Biotechnology Information (NCBI)
  • World Federation of Neurology (WFN)
  • Centers for Disease Control and Prevention (CDC)
  • Epilepsy Foundation
  • American Brain Foundation (ABF)
  • Brain Injury Association of America (BIAA)
  • Neurology Asia Journal
  • Alzheimer's Association
  • American Neurological Association (ANA)
  • European Journal of Neurology

Report Objectives

  • To define, describe, and forecast the brain monitoring market based on the product, procedure, modality, medical condition, end user, and region.
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges).
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall brain monitoring market.
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders.
  • To profile the key players in the market and comprehensively analyze their market shares and core competencies.
  • To forecast the size of the market segments with respect to four main regions, namely, North America, Asia Pacific, Europe, Latin America, and Middle East & Africa.
  • To track and analyze competitive developments such as new product launches, agreements, collaborations, and expansions.

Available Customizations:

MarketsandMarkets offers the following customizations for this market report:

Company Information

  • Profiling of additional market players (up to 3)
  • Additional country-level analysis of sub-segments such as media, reagents, flow cytometers, and centrifuges.
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
MD 1369
Published ON
Jan, 2024
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Brain Monitoring Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback